However, pharmacovigilance data indicated that the prolonged use of androgen receptor antagonists and/or progesterone receptor agonists (cyproterone acetate, nomegestrol acetate) results in increased meningioma incidence [82,83], making rather complex the prognostic or therapeutic evaluation of these receptors. This evidence concerns the gene PGR and meningioma.